More like the expected preliminary data readout from the Path BioAnlytics tests of our compounds as forecast in the 16 July 2020 announcement. Given these were effectively tested on an "ex vivo respiratory organoid model", even with very positive results we have a long way to go before producing an accepted treatment.
More like the expected preliminary data readout from the Path...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
0.005(0.97%) |
Mkt cap ! $120.5M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 54.0¢ | 52.0¢ | $4.485K | 8.497K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 14897 | 2 |
View Market Depth
| Last trade - 15.47pm 04/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |